(Q48210674)
Statements
1 reference
Pembrolizumab, pomalidomide, and low-dose dexamethasone for relapsed/refractory multiple myeloma (English)
1 reference
Elizabeth Hyjek
Ning Ma
Ahmet Dogan
Aaron P Rapoport
Mehmet Kocoglu
Emily Lederer
Sunita Philip
Todd Milliron
Cameron Dell
Olga Goloubeva
1 May 2017
1 reference